The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

Completed · Not applicable

Conditions studied: Coronary Artery Disease, Chest Pain

In brief

This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.

Key facts

Study ID

NCT00644657

Run by

University of Oklahoma

People needed

27

Starts

2007-03-01

Expected to finish

2008-09-01

Last updated by the study team

2011-10-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients given clopidogrel loading dose before scheduled catheterization or percutaneous intervention

You may not qualify if…

• Acute coronary syndrome
• Unable to tolerate clopidogrel

Where it is running

• VA Medical Center, 1F187 — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.